Get started
Author

David A. L. Newcombe

Observed names: D A L Newcombe, D. Newcombe, DAVID A. L. NEWCOMBE, David A L Newcombe, David A. Newcombe, David A.L Newcombe, David A.L. Newcombe, David Newcombe, David Newcombe (273028), Newcombe, D, Newcombe, David, Newcombe, David A. L.
Observed institutions: The University of Sydney, University of Auckland, University of the Sunshine Coast, University of California San Diego, Waitemata District Health Board, World Health Organization, South Eastern Sydney Local Health District, Hunter New England Local Health District, Health and Research Collaborative, Adelaide University, The University of Adelaide, University of Newcastle Australia
ORCID: 0000-0002-6268-786X
Observed ORCID: 0000-0002-6268-786X
OpenAlex ID: A5080398922
Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site
2005 · DAVID A. L. NEWCOMBE, RACHEL E. HUMENIUK, et al. · Drug and Alcohol Review · 291
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS
2008 · Peter Lawrinson, Robert Ali, et al. · Addiction · 242
PDF
A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health‐care settings in four countries
2011 · Rachel Humeniuk, Robert Ali, et al. · Addiction · 226
Methylenedioxymethamphetamine (MDMA) in Psychiatry
2018 · Susan Schenk, David Newcombe · Journal of Clinical Psychopharmacology · 53
Subjective and physiological responses among racemic‐methadone maintenance patients in relation to relative (S)‐ vs. (R)‐methadone exposure
2004 · Timothy B. Mitchell, Kyle R. Dyer, et al. · British Journal of Clinical Pharmacology · 50
Pharmacokinetics of cytisine, an α4β2 nicotinic receptor partial agonist, in healthy smokers following a single dose
2014 · Soo Hee Jeong, David Newcombe, et al. · Drug Testing and Analysis · 49
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines
2018 · Nicholas Lintzeris, Lauren A. Monds, et al. · Journal of Addiction Medicine · 36
The new psychoactive substances regime in New Zealand: a different approach to regulation
2013 · Chris Wilkins, Janie Sheridan, et al. · Journal of Psychopharmacology · 35
Ibogaine for treating drug dependence. What is a safe dose?
2016 · L.J. Schep, R.J. Slaughter, et al. · Drug and Alcohol Dependence · 32
Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis
2004 · David A.L. Newcombe, Felix Bochner, et al. · Drug and Alcohol Dependence · 28
Investigating Betel Nut Use, Antecedents and Consequences: A Review of Literature
2019 · Ye Jin Joo, David Newcombe, et al. · Substance Use & Misuse · 27
Relationship between LAAM–methadone preference and treatment outcomes
2002 · Jason M White, Cath Danz, et al. · Drug and Alcohol Dependence · 26
Alcohol use trajectories across the life course: Influences of childhood predictors and consequences for late-life health
2021 · Ágnes Szabó, Andy Towers, et al. · Drug and Alcohol Dependence · 20
The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
2018 · Chris Bullen, Marjolein Verbiest, et al. · BMC Public Health · 20
Self‐Reported Risk‐Taking Behavior During Matched‐Frequency Sessions of Alcohol Versus Combined Alcohol and Energy Drinks Consumption: Does Co‐Ingestion Increase Risk‐Taking?
2015 · Amy Peacock, Nicolas Droste, et al. · Alcoholism Clinical and Experimental Research · 20
Illicit drug use among New Zealand gay and bisexual men: Prevalence and association with sexual health behaviours
2017 · Peter Saxton, David Newcombe, et al. · Drug and Alcohol Review · 18
Manaaki – a cognitive behavioral therapy mobile health app to support people experiencing gambling problems: a randomized control trial protocol
2020 · Gayl Humphrey, Joanna Chu, et al. · BMC Public Health · 16
PDF
Ascending single dose pharmacokinetics of cytisine in healthy adult smokers
2018 · Soo Hee Jeong, Janie Sheridan, et al. · Xenobiotica · 16
A systematic review exploring the presence of vicarious trauma, compassion fatigue, and secondary traumatic stress in alcohol and other drug clinicians
2017 · Huggard, P, Law, J, et al. · ResearchSpace (University of Auckland) · 16
Guidelines for the medical management of patients with methamphetamine-induced psychosis
2006 · Cassandra Mclver, Catherine McGregor, et al. · 15
Adapting an Evidence-Based e-Learning Cognitive Behavioral Therapy Program Into a Mobile App for People Experiencing Gambling-Related Problems: Formative Study
2022 · Gayl Humphrey, Joanna Ting Chu, et al. · JMIR Formative Research · 14
PDF
Hazardous Drinking Prevalence and Correlates in Older New Zealanders: A Comparison of the AUDIT-C and the CARET
2018 · Andy Towers, Ágnes Szabó, et al. · Journal of Aging and Health · 14
Plasma concentrations of cytisine, a commercially available plant-based alkaloid, in healthy adult smokers taking recommended doses for smoking cessation
2017 · Soo Hee Jeong, Janie Sheridan, et al. · Xenobiotica · 14
Qualitative Field Study for users of Performance and Image Enhancing Drugs
2008 · Dennington, C Finney-Lamb, et al. · 14
Challenges of virtual talking therapies for substance misuse in New Zealand during the COVID-19 pandemic: an opinion piece.
2020 · Susanna Galea-Singer, David Newcombe, et al. · PubMed · 13
Works count: 98
Citation count: 1,543
H-index: 16
I10-index: 29
Year
Topic
Type